Swiss National Bank Boosts Stock Position in Axon Enterprise, Inc (NASDAQ:AXON)

Key Points

• The Swiss National Bank increased its stake in Axon Enterprise by 0.7%, owning approximately $107.45 million worth of shares as of the end of the last quarter.
• Insider transactions indicate significant selling activity, with Directors Caitlin Elizabeth Kalinowski and Michael Garnreiter reducing their holdings by 21.21% and 25.00% respectively.
• Research analysts have a consensus rating of "Moderate Buy" for Axon Enterprise, with price targets ranging from $725.00 to $870.00.

Swiss National Bank boosted its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 0.7% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 204,300 shares of the biotechnology company's stock after buying an additional 1,400 shares during the quarter. Swiss National Bank owned approximately 0.26% of Axon Enterprise worth $107,452,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of AXON. TCTC Holdings LLC increased its holdings in Axon Enterprise by 75.0% in the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock valued at $29,000 after buying an additional 24 shares during the last quarter. Fourth Dimension Wealth LLC acquired a new position in Axon Enterprise in the fourth quarter valued at $30,000. Bartlett & CO. Wealth Management LLC boosted its stake in Axon Enterprise by 132.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after acquiring an additional 33 shares in the last quarter. Catalyst Capital Advisors LLC acquired a new position in Axon Enterprise in the first quarter valued at $32,000. Finally, Alpine Bank Wealth Management acquired a new position in Axon Enterprise in the first quarter valued at $40,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Insiders Place Their Bets

In other news, Director Caitlin Elizabeth Kalinowski sold 1,300 shares of Axon Enterprise stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $738.84, for a total value of $960,492.00. Following the sale, the director owned 4,829 shares of the company's stock, valued at $3,567,858.36. The trade was a 21.21% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Michael Garnreiter sold 5,913 shares of the firm's stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $760.00, for a total transaction of $4,493,880.00. Following the completion of the sale, the director owned 17,740 shares of the company's stock, valued at $13,482,400. This trade represents a 25.00% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 34,642 shares of company stock valued at $25,090,528. Corporate insiders own 4.40% of the company's stock.

Wall Street Analyst Weigh In

AXON has been the subject of several research analyst reports. Needham & Company LLC set a $870.00 price objective on shares of Axon Enterprise and gave the company a "buy" rating in a research note on Tuesday, August 5th. JMP Securities upped their price objective on shares of Axon Enterprise from $725.00 to $825.00 and gave the company a "market outperform" rating in a research note on Tuesday, July 22nd. The Goldman Sachs Group upped their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research note on Wednesday, May 14th. Wolfe Research initiated coverage on shares of Axon Enterprise in a research note on Monday, July 7th. They issued an "outperform" rating for the company. Finally, Raymond James Financial restated an "outperform" rating and issued a $855.00 price objective (up previously from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Two equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, Axon Enterprise currently has a consensus rating of "Moderate Buy" and a consensus price target of $837.69.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $842.50 on Friday. The stock has a market capitalization of $66.14 billion, a price-to-earnings ratio of 208.02, a PEG ratio of 93.35 and a beta of 1.36. The company has a 50-day simple moving average of $774.27 and a 200-day simple moving average of $665.08. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.62 and a current ratio of 2.95. Axon Enterprise, Inc has a one year low of $346.71 and a one year high of $885.91.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.58. The business had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business's quarterly revenue was up 32.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.20 earnings per share. On average, analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.